Daewoong pharmaceutical

069620.KO

101.89 USD

-0.45

-0.44%

Overview

Last close

101.89 usd

Market cap

1.17B usd

52 week high

119.39 usd

52 week low

72.15 usd

Target price

144.39 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.1501

Price/Book Value

2.059

Enterprise Value

1.55B usd

EV/Revenue

1.5246

EV/EBITDA

19.2782

Key financials

Revenue TTM

1.02B usd

Gross Profit TTM

524.43M usd

EBITDA TTM

138.91M usd

Earnings per Share

N/A usd

Dividend

0.43 usd

Total assets

1.34B usd

Net debt

368.41M usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.